Recombinant interferon-gamma differently affects DQA and DRA gene expression in two human melanoma clones:

C Castelli1, M Sensi, G Parmiani

  • 1Division of Experimental Oncology D, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy.

Insights

Recombinant interferon gamma (rINF-gamma) differentially regulates human leukocyte antigen (HLA) DQ gene expression in melanoma. This regulation occurs at both transcriptional and posttranscriptional levels, involving a short-lived protein stabilizing DQ mRNA.

Area of Science:

  • Immunogenetics
  • Molecular Biology
  • Cancer Research

Background:

  • Human melanoma cells exhibit differential responses to recombinant interferon gamma (rINF-gamma).
  • Previous studies showed distinct HLA class II gene expression patterns in two melanoma clones (9229/18 and 9229/5) upon rINF-gamma treatment.
  • Clone 9229/18 showed coordinate DR and DQ gene expression, while clone 9229/5 showed DR but not DQ gene upregulation.

Purpose of the Study:

  • To investigate the molecular mechanisms behind differential HLA DQ gene regulation by rINF-gamma in human melanoma.
  • To analyze DQA gene regulation at both transcriptional and posttranscriptional levels.
  • To identify factors influencing DQA mRNA stability.

Main Methods:

  • Nuclear run-on assays to assess gene transcription rates.
  • Analysis of steady-state mRNA levels and cell surface antigen expression.
  • mRNA turnover studies using actinomycin D and cycloheximide to evaluate mRNA stability.
  • Treatment of melanoma cell clones with rINF-gamma.

Main Results:

  • rINF-gamma induced coordinate transcriptional activation of DRA and DQA genes in clone 9229/18.
  • In clone 9229/5, rINF-gamma strongly increased DRA transcription but not DQA transcription.
  • A short-lived protein was found to be essential for stabilizing human DQA mRNA in melanoma cells.
  • Basal transcription rates for class II genes did not yield mature cytoplasmic mRNA in either clone.

Conclusions:

  • DQA gene expression in melanoma is tightly regulated at both transcriptional and posttranscriptional levels.
  • rINF-gamma can differentially regulate DQA and DRA genes transcriptionally in specific melanoma clones.
  • Posttranscriptional regulation of DQA mRNA stability is mediated by a short-lived protein, highlighting complex gene expression control in melanoma.

Related Concept Videos

Exon Recombination02:32

Exon Recombination

The evolution of new genes is critical for speciation. Exon recombination, also known as exon shuffling or domain shuffling, is an important means of new gene formation. It is observed across vertebrates, invertebrates, and in some plants such as potatoes and sunflowers. During exon recombination, exons from the same or different genes recombine and produce new exon-intron combinations, which might evolve into new genes. 
Exon shuffling follows “splice frame rules.” Each exon has three reading...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...